Global Multiplex Assay Market (2021 to 2028) - Featuring Abcam, Agilent Technologies and Bio Rad Laboratories Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Multiplex Assay Market 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The publisher suggests that the global market for multiplex assay is estimated to experience growth at a CAGR of 8.67% over the forecast period 2021-2028.

Companies Mentioned

• Abcam
• Agilent Technologies Inc
• Becton Dickinson and Company
• Bio Rad Laboratories Inc
• Bio Techne Corporation
• F Hoffmann La Roche
• Illumina Inc
• Luminex Corporation
• Merck Millipore
• Meso Scale Diagnostics LLC
• Olink Proteomics Ab
• Qiagen Nv
• Randox Laboratories Ltd
• Seegene Inc
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc

Factors such as the growing adoption of personalized medicines, coupled with the high adoption of multiplex assays over conventional methods, are supplementing the growth of the studied market.

Additionally, the rise in function by various government agencies and opportunities in emerging economies are opening new avenues for the global market. However, the shortage of skilled professionals and legal trends pertaining to environmental safety hamper the multiplex assay market's growth.

The global multiplex assay market covers the regions of North America, the Asia-Pacific, Latin America, Europe, and the Middle East and Africa.

Geographically, the Asia-Pacific is estimated to become the fastest-growing region in the multiplex assay market over the forecast market. The market's growth is mainly owing to the ever-increasing demand for healthcare services, coupled with the rise in the number of hospitals in countries like India and China. Moreover, the development of research and development infrastructure is anticipated to offer new opportunities for the reviewed market. Other than this, the rise in healthcare reforms and technological advancements is another set of factors supporting the multiplex assay market's growth across the region.

Key Topics Covered:

1. Global Multiplex Assay Market - Summary

2. Industry Outlook
2.1. Impact of COVID-19 on Multiplex Assay Market
2.2. Key Insights
2.3. Porter's Five Forces Model
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute Products
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Competitive Rivalry
2.4. Key Buying Outlook
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Key Market Strategies
2.7.1. Contracts and Partnerships
2.7.2. Business Expansions, Announcements, & Divestitures
2.7.3. Acquisitions & Mergers
2.7.4. New Product Launches & Developments
2.8. Key Drivers
2.8.1. Adoption of Personalized Medicines
2.8.2. High Adoption of Multiplex Assays Over Traditional Methods
2.9. Key Restraints
2.9.1. Dearth of Skilled Professionals
2.9.2. Legal Trends Related to Environmental Safety
2.10. Key Opportunities
2.10.1. Funding for R&D Activities by Various Government Agencies and Companies
2.10.2. Emerging Economies Offering Lucrative Growth Opportunities

3. Global Multiplex Assay Market - by Product and Service
3.1. Reagents and Consumables
3.2. Instruments and Accessories
3.3. Software and Services

4. Global Multiplex Assay Market - by Type
4.1. Protein-Based Multiplex Assay
4.2. Nucleic Acid-Based Multiplex Assay
4.3. Other Multiplex Assays

5. Global Multiplex Assay Market - by Application
5.1. Research and Development
5.2. Clinical Diagnostics
5.3. Companion Diagnostics

6. Global Multiplex Assay Market - by Technology
6.1. Multiplex Protein Microarray
6.2. Multiplex Pcr
6.3. Other Technologies

7. Global Multiplex Assay Market - by Industry Verticals
7.1. Pharmaceutical & Biotechnology Companies
7.2. Research Institutes
7.3. Clinical Laboratories
7.4. Hospitals

8. Global Multiplex Assay Market - Regional Outlook

9. Competitive Landscape

10. Research Methodology & Scope

For more information about this report visit https://www.researchandmarkets.com/r/b8nsvn